Scopia Management, Inc., 10% Owner at ACORDA THERAPEUTICS INC (ACOR), sold 727,668 shares at $30.77 ($22.3M) on 2018-06-18, disclosed to the SEC on 2018-06-20.
Open-market sale of $22.3M ACOR by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $30.77 | 243,414 | $7.5M | 33.5% |
| 2 | $30.77 | 243,414 | $7.5M | 33.5% |
| 3 | $30.63 | 91,070 | $2.8M | 12.5% |
| 4 | $30.63 | 91,070 | $2.8M | 12.5% |
| 5 | $30.37 | 58,700 | $1.8M | 8.0% |
| Total | $30.70 avg | 727,668 |
| $22.3M |
| 100% |
| Filing → |
| ITRI | SELL | 2019-04-16 | $5.9M | — | Filing → |
| ITRI | SELL | 2019-03-29 | $3.0M | — | Filing → |
| ITRI | SELL | 2019-03-25 | $5.8M | — | Filing → |